Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)-Reference-Cited by-同舟云学术

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)

Published:2009-06 Issue:2 Volume:64 Page:177-184
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Biedenbach Douglas J.,Jones Ronald N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997–2004)

2. Activity of dalbavancin tested against Staphylococcus spp. and β-haemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States;Biedenbach;J. Clin. Microbiol.,2007

3. Epidemiology of methicillin-resistant Staphylococcus aureus;Boucher;Clin. Infect. Dis.,2008

4. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system;Bowker;J. Antimicrob. Chemother.,2006

5. Performance standards for antimicrobial disk susceptibility tests; approved standard—ninth edition, M2-A9;Clinical and Laboratory Standards Institute (CLSI),2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017–2018), and on clonal distribution of MRSA;International Journal of Antimicrobial Agents;2022-02

2. Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Anti-infective Therapy;2021-10-06

3. Systematic review and meta-analysis on the safety of dalbavancin;Expert Opinion on Drug Safety;2021-06-07

4. Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland;Diagnostic Microbiology and Infectious Disease;2019-12

5. The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery;Journal of Chemotherapy;2017-11-23